FDA — authorised 14 July 1995
- Application: NDA050715
- Marketing authorisation holder: NOVARTIS
- Status: supplemented
🇺🇸 Neoral in United States
FDA authorised Neoral on 14 July 1995
Marketing authorisations
FDA — authorised 14 July 1995
- Application: NDA050716
- Marketing authorisation holder: NOVARTIS
- Status: supplemented
FDA
- Status: approved
Other Immunology approved in United States
Frequently asked questions
Is Neoral approved in United States?
Yes. FDA authorised it on 14 July 1995; FDA authorised it on 14 July 1995; FDA has authorised it.
Who is the marketing authorisation holder for Neoral in United States?
NOVARTIS holds the US marketing authorisation.